Page last updated: 2024-08-25

nedaplatin and vindesine

nedaplatin has been researched along with vindesine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asamoto, H; Fukuoka, M; Furuse, K; Kimura, I; Niitani, H; Sakuma, A; Yamaguchi, Y	1
Karato, A; Miya, T; Saijo, N; Sasaki, Y	1
Ota, K	1
Eguchi, K; Harada, M; Kiura, K; Miyamoto, H; Segawa, Y; Shibayama, T; Tabata, M; Takata, I; Takigawa, N; Ueoka, H	1
Boku, N; Fukutomi, A; Hasuike, N; Hironaka, S; Inui, T; Ono, H; Onozawa, Y; Yamaguchi, Y; Yamazaki, K; Yasui, H; Yoshino, T	1

Reviews

1 review(s) available for nedaplatin and vindesine

Article	Year
[Nedaplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Urogenital Neoplasms; Vindesine	1996

Article

Year

[Nedaplatin].

Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:3

Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Urogenital Neoplasms; Vindesine

1996

Trials

2 trial(s) available for nedaplatin and vindesine

Article	Year
[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:7 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Vindesine	1992
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Recurrence; Survival Analysis; Vindesine	2000

Article

Year

[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].

Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:7

Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Vindesine

1992

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.

Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:4

Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Recurrence; Survival Analysis; Vindesine

2000

Other Studies

2 other study(ies) available for nedaplatin and vindesine

Article	Year
Pharmacokinetic study of mitomycin C with emphasis on the influence of aging. Japanese journal of cancer research : Gann, 1992, Volume: 83, Issue:12 Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vindesine	1992
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum. International journal of clinical oncology, 2008, Volume: 13, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine	2008

Article

Year

Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.

Japanese journal of cancer research : Gann, 1992, Volume: 83, Issue:12

Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vindesine

1992

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.

International journal of clinical oncology, 2008, Volume: 13, Issue:2

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine

2008